Oragenics, Inc. (OGEN)
0.5399
+0.02
(+3.81%)
USD |
NYAM |
Aug 26, 13:52
Oragenics Market Cap : 2.436M for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 2.347M |
| August 24, 2026 | 2.344M |
| August 21, 2026 | 2.369M |
| August 20, 2026 | 2.436M |
| August 19, 2026 | 2.392M |
| August 18, 2026 | 2.464M |
| August 17, 2026 | 2.414M |
| August 14, 2026 | 2.404M |
| August 13, 2026 | 2.392M |
| August 12, 2026 | 2.420M |
| August 11, 2026 | 2.477M |
| August 10, 2026 | 2.398M |
| August 07, 2026 | 2.406M |
| August 06, 2026 | 2.378M |
| August 05, 2026 | 2.363M |
| August 04, 2026 | 2.407M |
| August 03, 2026 | 2.316M |
| July 31, 2026 | 2.188M |
| July 30, 2026 | 2.145M |
| July 29, 2026 | 2.173M |
| July 28, 2026 | 2.175M |
| July 27, 2026 | 2.192M |
| July 24, 2026 | 2.236M |
| July 23, 2026 | 2.210M |
| July 22, 2026 | 2.319M |
| Date | Value |
|---|---|
| July 21, 2026 | 2.363M |
| July 20, 2026 | 2.368M |
| July 17, 2026 | 2.405M |
| July 16, 2026 | 2.441M |
| July 15, 2026 | 2.450M |
| July 14, 2026 | 2.476M |
| July 13, 2026 | 2.494M |
| July 10, 2026 | 2.565M |
| July 09, 2026 | 2.522M |
| July 08, 2026 | 2.588M |
| July 07, 2026 | 2.504M |
| July 06, 2026 | 2.538M |
| July 02, 2026 | 2.560M |
| July 01, 2026 | 2.652M |
| June 30, 2026 | 2.540M |
| June 29, 2026 | 2.582M |
| June 26, 2026 | 2.569M |
| June 25, 2026 | 2.505M |
| June 24, 2026 | 2.566M |
| June 23, 2026 | 2.573M |
| June 22, 2026 | 2.529M |
| June 18, 2026 | 2.404M |
| June 17, 2026 | 2.669M |
| June 16, 2026 | 2.672M |
| June 15, 2026 | 2.730M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.107B |
| Alnylam Pharmaceuticals, Inc. | 32.30B |
| Anika Therapeutics, Inc. | 284.25M |
| Savara, Inc. | 1.159B |
| Vericel Corp. | 2.179B |
Market Cap Related Metrics
| Price to Book Value | 0.6636 |
| Price | 0.5399 |
| Earnings Yield | -663.6% |